IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.159
EU - Europa 2.270
AS - Asia 1.001
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
SA - Sud America 2
Totale 6.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.142
PL - Polonia 1.137
CN - Cina 507
UA - Ucraina 365
DE - Germania 195
SG - Singapore 191
IT - Italia 146
HK - Hong Kong 128
FI - Finlandia 121
GB - Regno Unito 79
IE - Irlanda 65
TR - Turchia 62
RU - Federazione Russa 61
VN - Vietnam 43
IN - India 31
FR - Francia 27
CZ - Repubblica Ceca 22
ID - Indonesia 17
CA - Canada 15
SE - Svezia 15
NL - Olanda 10
BE - Belgio 9
IL - Israele 7
ES - Italia 5
EU - Europa 5
IR - Iran 5
MA - Marocco 4
LT - Lituania 3
AU - Australia 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
CR - Costa Rica 1
EC - Ecuador 1
IS - Islanda 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 6.446
Salva come PNG Salva come JPEG
Città #
Warsaw 1.137
Woodbridge 415
Fairfield 382
Jacksonville 275
Houston 238
Ashburn 233
Ann Arbor 194
Cambridge 178
Wilmington 171
Chandler 161
Singapore 156
Seattle 143
Hong Kong 128
Princeton 120
Nanjing 97
New York 96
Beijing 89
Dearborn 82
Helsinki 68
Dublin 63
Istanbul 58
Dong Ket 42
Moscow 33
Brescia 31
Jinan 31
Nanchang 31
Boardman 30
Lancaster 30
Milan 29
Shenyang 29
Shanghai 28
Des Moines 25
Jiaxing 22
San Diego 22
Changsha 19
Kunming 18
Tianjin 18
Hebei 17
Jakarta 16
Munich 15
Olomouc 15
Verona 15
Hangzhou 14
Zhengzhou 13
Haikou 12
London 12
Toronto 12
San Francisco 11
Florence 10
Augusta 9
Brussels 9
Leawood 9
San Mateo 9
Phoenix 8
Brno 7
Ningbo 7
Taizhou 7
Beersheba 6
Dronten 6
Lanzhou 6
Monmouth Junction 6
Taiyuan 6
Hefei 5
Amsterdam 4
Ardabil 4
Changchun 4
Fuzhou 4
Lappeenranta 4
Los Angeles 4
Barcelona 3
Bernareggio 3
Fiorenzuola D'arda 3
Kilburn 3
Kocaeli 3
Leipzig 3
Mumbai 3
Norwalk 3
Orange 3
Pian Camuno 3
Santa Clara 3
Washington 3
Athens 2
Donegal 2
Guangzhou 2
Indiana 2
Islamabad 2
Jinhua 2
Markham 2
Palermo 2
Rabat 2
Rochester 2
Romola 2
Sant'anastasia 2
Tallinn 2
A Coruña 1
Acton 1
Almaty 1
Amman 1
Baku 1
Bangalore 1
Totale 5.276
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 279
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 244
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 229
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 228
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 225
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 215
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 211
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 179
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 168
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 165
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 163
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 158
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 147
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 128
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 126
Sialic acid as a target for the development of novel antiangiogenic strategies 122
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 120
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 116
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 116
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 116
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 111
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 105
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 105
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 103
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 99
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 99
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 98
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 95
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 93
Role of heparan sulfate proteoglycans in HIV-1 Tat-induced transendothelial migration of lymphoid cells 91
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF. 88
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF-receptors 87
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 84
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain 81
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 80
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 76
The basic domain in HIV-1 Tat as a target for polysulfated heparin-mimicking extracellular Tat antagonists 74
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 74
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 73
Recent Strategic Advances in CFTR Drug Discovery: An Overview 71
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 69
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes 69
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 69
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 68
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells 68
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biologiocal activity of extracellular Tat 65
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 64
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 63
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 62
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 62
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 60
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes 59
Thrombospondin-1: the paradigm of antiangiogenic agents endowed with multiple mechanisms of action 59
Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF 56
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium 51
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS 50
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 50
Glycomics and angiogenesis: biological implications and therapeutical exploiting 47
heparan sulfate proteoglycans/HIV-1 Tat interaction: a mechanical and functional bridge between lymphoid and endothelial cells 46
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 38
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 35
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 32
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 30
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 28
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 14
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 12
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 9
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples 4
Totale 6.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.154 0 0 0 0 0 216 203 180 141 236 81 97
2020/20211.091 37 101 44 130 73 124 42 140 131 79 115 75
2021/2022540 15 108 8 16 5 29 40 40 24 75 44 136
2022/2023438 64 19 26 19 29 125 7 46 63 3 12 25
2023/2024618 36 8 63 35 28 122 17 20 139 16 17 117
2024/2025423 20 10 7 188 94 104 0 0 0 0 0 0
Totale 6.581